Neuronetics, Inc. (STIM)

Neuronetics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	59.68	70.34	94.14	48.96	75.71
Short-Term Investments	2.96	1.77	2.27	1.89	0.88
Cash & Cash Equivalents	62.64	72.11	96.41	50.84	76.59
Cash Growth	-13.13%	-25.21%	89.63%	-33.61%	-26.77%
Receivables	15.78	13.59	17.82	7.17	6.57
Inventory	8.09	8.9	6.56	3.72	2.78
Other Current Assets	7.28	4.17	-5.46	3.28	2.52
Total Current Assets	93.79	98.77	115.33	65.01	88.45
Property, Plant & Equipment	4.78	5.32	5.1	4.15	4.9
Long-Term Investments	4.46	1.58	1.7	2.33	1.73
Other Long-Term Assets	12.8	11.21	19.09	7.17	5.08
Total Long-Term Assets	22.04	18.12	25.89	13.65	11.72
Total Assets	115.83	116.88	141.22	78.66	100.17
Accounts Payable	4.75	2.43	4.3	3.75	4.63
Deferred Revenue	1.82	2.81	3.97	3.76	4.33
Current Debt	0.85	13.95	0.67	0.59	11.81
Other Current Liabilities	12.4	14.01	6.76	5.58	6.93
Total Current Liabilities	19.81	33.2	15.7	13.68	27.69
Long-Term Debt	61.63	25.8	38.87	37.74	22.52
Other Long-Term Liabilities	0.2	0.83	1.47	1.74	2.11
Total Long-Term Liabilities	61.83	26.63	40.35	39.48	24.62
Total Liabilities	81.64	59.82	56.05	53.16	52.32
Total Debt	62.47	39.75	39.54	38.34	34.33
Debt Growth	57.19%	0.51%	3.15%	11.68%	12.93%
Retained Earnings	-376.08	-345.89	-308.73	-277.54	-250.09
Shareholders' Equity	34.19	57.06	85.18	25.49	47.85
Net Cash / Debt	0.16	32.36	56.87	12.51	42.26
Net Cash / Debt Growth	-99.49%	-43.09%	354.62%	-70.40%	-43.03%
Net Cash Per Share	0.01	1.20	2.23	0.66	2.30
Working Capital	73.98	65.57	99.63	51.33	60.76
Book Value Per Share	1.19	2.12	3.34	1.35	2.60

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).